Dr. Sol J. Barer to Receive PM360's 2025 Lifetime Achievement Award

PM360 Announces Dr. Sol J. Barer as 2025 Lifetime Achievement Award Winner

On June 25, 2025, PM360 proudly announced that Dr. Sol J. Barer of Teva Pharmaceuticals has been selected as the recipient of its prestigious Lifetime Achievement Award. This notable recognition will be awarded during the 17th annual Trailblazer Awards Gala, set to take place at Gotham Hall in New York City on September 30.

Founded in 2009, the Trailblazer Awards celebrates outstanding contributions in the life sciences marketing industry, recognizing companies, marketers, and initiatives that have exhibited significant innovation and success. As a leading publication in the life sciences marketing domain, PM360 aims to spotlight those who have made impactful strides in this rapidly evolving field.

Fred Hassan, who nominated Dr. Barer and is a previous award winner, praised his transformative leadership within the biotechnology sector. He emphasized that Dr. Barer is not only an accomplished scientist and entrepreneur but also a compassionate individual dedicated to bettering the industry and society.

Dr. Barer is particularly renowned for his influential role at Celgene Corporation, where he served as both Chairman and CEO. He also played a pivotal role in establishing the biotechnology division at Celanese Research, which subsequently evolved into Celgene, significantly influencing the global biotech landscape. Currently, he holds the chairmanship of boards at Teva Pharmaceutical Industries, Centrexion, and the HMH Center for Discovery and Innovation.

Beyond his corporate engagements, Dr. Barer's entrepreneurial passion is evident through his contributions to MIG, an organization that fosters Israeli biotech initiatives, and his advisory position at the Israel Biotechnology Fund. His dedication to education and policy advancement is underscored by his leadership on the Governor's Advisory Committee for the University of Medicine and Dentistry of New Jersey and his various board appointments, which include prestigious institutions like Rutgers University and BioNJ.

Throughout his illustrious career, Dr. Barer has garnered widespread recognition for his contributions, featuring on Scientific American's 'Worldview 100' list and receiving numerous accolades such as the 'Outstanding Global Director' title from the Financial Times and the 'Lifetime Achievement Award' from the International Myeloma Foundation. His philanthropic efforts have also been acknowledged by several organizations, including Rambam Healthcare Center in Israel and Overlook Hospital.

An accomplished academic, Dr. Barer earned a Ph.D. in Organic Chemistry from Rutgers University and has received an honorary LL.D. from the Rabbinical College of America. Together with his wife, Meri, he has celebrated over 56 years of marriage and is the proud father of four children and grandfather to fifteen grandchildren.

This recognition from PM360 not only honors Dr. Barer's career achievements but also highlights his profound impact on the life sciences sector. With a relentless commitment to innovation, education, and community service, he exemplifies the qualities that the Trailblazer Awards seek to honor.

About PM360

PM360 stands as an essential read for marketing professionals engaged in the pharmaceutical, biotech, diagnostics, and medical device industries. With a focus on delivering a comprehensive range of practical insights for product managers and pharmaceutical marketers, this monthly publication addresses critical decision-making issues, including cutting-edge strategy implementation, market trends, and technological advances. Through its engaging editorial approach, PM360 continues to serve as a vital resource for industry leaders aiming to stay competitive in the highly regulated healthcare environment.